Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamza Celik

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Blood Cancer Discovery|April 8, 2022
Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21Christine R Zhang, Elizabeth L Ostrander, Ostap Kukhar, et al.
Leukemia|April 3, 2019
Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesisCates Mallaney, Elizabeth L Ostrander, Hamza Celik, et al.
Blood Advances|October 13, 2021
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibitionTim Kong, Angelo B A Laranjeira, Taylor B Collins, et al.
Cell Reports|April 5, 2018
Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In VivoMira Jeong, Hyun Jung Park, Hamza Celik, et al.
Cell Stem Cell|August 19, 2014
Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cellsGrant A Challen, Deqiang Sun, Allison Mayle, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow TransplantationWentao Han, Hassan Bjeije, Hamza Celik, et al.
Cancer Cell|November 14, 2018
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor CellsHamza Celik, Won Kyun Koh, Ashley C Kramer, et al.
Nature Cancer|December 29, 2022
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progressionTim Kong, Angelo B A Laranjeira, Kangning Yang, et al.
Blood Neoplasia|June 24, 2025
BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesisWangisa Dunuwille, William C Wilson, Hassan Bjeije, et al.
Cancer Discovery|July 1, 2021
A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative NeoplasmsHamza Celik, Ethan Krug, Christine R Zhang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Blood Cancer Discovery|April 8, 2022
Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21Christine R Zhang, Elizabeth L Ostrander, Ostap Kukhar, et al.
Leukemia|April 3, 2019
Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesisCates Mallaney, Elizabeth L Ostrander, Hamza Celik, et al.
Blood Advances|October 13, 2021
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibitionTim Kong, Angelo B A Laranjeira, Taylor B Collins, et al.
Cell Reports|April 5, 2018
Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In VivoMira Jeong, Hyun Jung Park, Hamza Celik, et al.
Cell Stem Cell|August 19, 2014
Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cellsGrant A Challen, Deqiang Sun, Allison Mayle, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow TransplantationWentao Han, Hassan Bjeije, Hamza Celik, et al.
Cancer Cell|November 14, 2018
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor CellsHamza Celik, Won Kyun Koh, Ashley C Kramer, et al.
Nature Cancer|December 29, 2022
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progressionTim Kong, Angelo B A Laranjeira, Kangning Yang, et al.
Blood Neoplasia|June 24, 2025
BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesisWangisa Dunuwille, William C Wilson, Hassan Bjeije, et al.
Cancer Discovery|July 1, 2021
A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative NeoplasmsHamza Celik, Ethan Krug, Christine R Zhang, et al.
Pageof 3